13F-HR filed by Cormorant Asset Management, LP
Cormorant Asset Management, LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 49 holding rows worth $1,714,347,327.
- Accession
- 0001583977-23-000005
- Filer
- CIK 1583977
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 49 entries on the cover page, a total value of $1,714,347,327 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,714,347,327 with VALUE read as dollars as filed, 13F file number 028-15949. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerChen Bihua028-15950
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 8,142,100 | $464,099,700 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 4,662,530 | $122,950,916 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 9,923,689 | $114,122,424 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 2,150,000 | $77,142,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 2,000,000 | $76,080,000 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 3,850,000 | $57,403,500 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 4,504,764 | $55,633,835 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,056,373 | $53,262,327 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 3,570,872 | $49,135,202 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,225,000 | $47,027,750 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 2,621,422 | $46,582,669 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 2,879,424 | $43,824,833 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 665,000 | $33,901,700 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,101,904 | $32,770,625 | dollars as filed | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 4,204,364 | $32,289,516 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,361,460 | $28,413,670 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 1,182,263 | $26,246,239 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 3,200,000 | $25,568,000 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 140,000 | $23,672,600 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,900,000 | $21,755,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 10,813,246 | $21,302,095 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 1,561,696 | $21,192,215 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 2,625,000 | $21,131,250 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 850,000 | $19,486,250 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,946,887 | $16,885,663 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 1,216,712 | $16,620,286 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 9,500,000 | $16,245,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 600,000 | $16,188,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 575,000 | $14,518,750 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 700,000 | $14,042,000 | dollars as filed | |
| AXONICS INC | 05465P101 | COM | 250,000 | $14,030,000 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 2,353,141 | $13,083,464 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,762,115 | $11,242,294 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 225,000 | $10,570,500 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,000,000 | $9,750,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 450,000 | $9,220,500 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 593,043 | $5,960,082 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 325,000 | $5,401,500 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 350,000 | $4,641,000 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,087,807 | $4,285,960 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 561,600 | $3,633,552 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 616,786 | $3,324,477 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 612,079 | $2,937,979 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 81,963 | $2,131,858 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 1,181,115 | $2,007,896 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 92,293 | $1,302,256 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 392,167 | $913,749 | dollars as filed | |
| HARPOON THERAPEUTICS INC | 41358P205 | COM | 54,060 | $217,862 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 25,664 | $198,383 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001583977-23-000005 | this filing | 2023-11-14 | acceptance time not in the bulk data set |